Clinical Trial Update: Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 dose-escalation and efficacy study of GVAX Prostate Cancer Vaccine completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• GVAX Prostate Cancer Vaccine (GM-CSF expressing tumor cell vaccine)

Snippet

Sponsor: Cell Genesys | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED